QbTest, an objective ADHD test providing clinicians with actionable data for unbiased decision- making and support. The test, created by the global leader in ADHD testing Qbtech, is the first FDA-cleared solution to aid clinicians when diagnosing and treating ADHD in children, adolescents, and adults.
Qbtech offers both in-clinic and telehealth testing capabilities, which are conducted with a healthcare provider. Using a medical device administered on a computer, the in-clinic assessment uses an infrared tracking camera and head sensor to measure core ADHD symptoms – activity, inattention, and impulsivity – through a 15-20-minute computer- based test. Results are instantly analyzed and presented in a report that compares a patient’s results with a group of people of the same age and sex at birth without ADHD.
The data from QbTest can be utilized to enable clinicians to determine treatment effects more accurately and efficiently. This gives patients access to tailored treatment faster – an outcome that can increase the quality of life for patients.
“Qbtech prides itself on providing our clinicians with industry-leading technology to treat their patients,” said Tony Doyle, Commercial Director at Qbtech. “ADHD has a significant role in the current mental health crisis, and incorporating objective data into the standard treatment of care is critical for patients to be treated effectively and efficiently.”
Jennifer Schiavi FNP-BC joins the growing list of nearly 10,000 clinicians globally adopting objective measures to more accurately rule in or rule out ADHD for their patients. Qbtech has administered more than 600,000 tests, 120,000 conducted via telehealth.
The virtual QbCheck test is now being offered and implemented for all patients struggling with ADHD. For more information visit www.qbtech.com.
About Qbtech
Founded in 2002, Qbtech is a privately-owned Swedish company that has developed leading solutions and products for improving the diagnosis, treatment and follow-up of patients living with ADHD. Qbtech has operations in 13 countries and has offices in
Stockholm, Houston, and London. Qbtech is an award-winning company recognized for their innovation, most recently winning the 2022 HSJ Partnership Award for the ‘Best Mental Health Partnership with the NHS’. www.qbtech.com
コメント